Medical Device | January 16, 2025
Alleima completes the acquisition of medical components firm Endox
In 2023, Endox had revenues of approximately SEK 65 million
In 2023, Endox had revenues of approximately SEK 65 million
Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
Subscribe To Our Newsletter & Stay Updated
